Device General - Biliary Devices_endo

General - Biliary Devices

Payments companies reported to CMS as associated with General - Biliary Devices. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$91Kassociated payments (2023-2025)
512clinicians with associated payments
1company reporting

By year

2025 $91K

Payments reported as associated with General - Biliary Devices, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $70K
Surgery $3,128
Internal Medicine $2,829
Physician Assistant $987
Family $835
Nurse Practitioner $639

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with General - Biliary Devices

These are the largest totals companies reported as associated with General - Biliary Devices. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Kalpesh Patel Houston, TX Gastroenterology (Internal Medicine) $19,459.43
Amrita Sethi New York, NY Gastroenterology (Internal Medicine) $11,700.08
Rabia Latour New York, NY $7,255.38
Thiruvengadam Muniraj New Haven, CT Gastroenterology (Internal Medicine) $5,500.00
Neil Sharma Gilbert, AZ Gastroenterology (Internal Medicine) $2,500.00
Gustavo Churrango Worcester, MA Gastroenterology (Internal Medicine) $430.08
Blake Thompson Fernandina Beach, FL Gastroenterology (Internal Medicine) $426.73
Nirav Chiniwalla Concord, NC Gastroenterology (Internal Medicine) $413.45
Kalpesh Patel Concord, NC Gastroenterology (Internal Medicine) $413.44
Vinay Patel Concord, NC Internal Medicine $413.44

Prescribed General - Biliary Devices?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.